AllianceRx Walgreens Prime renews CE sponsorship for NASP members

AllianceRx Walgreens Prime has renewed its sponsorship of accredited, web-based continuing education customized for members of the National Association of Specialty Pharmacy, which includes AllianceRx Walgreens Prime pharmacists.

The CE content is accredited, managed and delivered through ProCE, a nationally recognized provider of CE for healthcare professionals.

"We are proud to again collaborate with NASP and ProCE. In 2019, more than 10,000 hours of specialty pharmacy-focused CE credit was awarded to our pharmacists as a result of the relationship," Rick Miller, VP of clinical and professional services, at AllianceRx Walgreens Prime said. "This shows our team members are committed to continual learning and want to provide the best possible care and support for specialty pharmacy patients."

This year, the program will include updated information addressing new treatment guidelines, algorithms, and FDA-approved medications for patients and disease states managed by a specialty pharmacy, NASP annual meeting program content, COVID-19 patient and pharmacy personnel education and management, and specialty pharmacy technician-specific programs.

“The renewed agreement helps ensure NASP members have access to best-in-class CE programs intended to help elevate and promote the practice of specialty pharmacy. The courses are provided by NASP, the only nonprofit national trade association representing specialty pharmacy, and serving as both the leading educational resource and national advocate for specialty pharmacy healthcare professionals and patients," said Sheila Arquette, executive director of NASP.

"In working with NASP, we continue to develop new content to meet the educational needs of AllianceRx Walgreens Prime specialty pharmacists," said Miller.

AllianceRx Walgreens Prime's on-demand CE courses cover a range of rare and chronic disease states managed within specialty pharmacy. New courses include Human Immunodeficiency Virus Treatment Strategies; Contemporary Practice Pearls for Pulmonary Arterial Hypertension; Specialty Pharmacy Pipeline Product Update; and Flu Vaccine Prophylaxis and Treatment Updates for Pharmacists. Modules on gene and cell therapy are currently in development for future release.

"Both AllianceRx Walgreens Prime and NASP devote significant resources to the continuing professional development of specialty pharmacists," said Richard Lewis, ProCE president and CEO. "As a CE provider, we are thrilled to see the dedication to patient care through professional education."